Stopping GLP-1 drugs can quickly erase cardiovascular benefits

Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S. adults now take these medications, which also provide cardiovascular ...

The next leap for AI scribes provides eyes in the clinic

The introduction of vision-enabled artificial intelligence (AI) to medical scribes—the recording devices used by doctors to document meetings with patients in real-time—could increase the accuracy of patient notes and ...

Nasal swab test spots early Alzheimer's signals

Alzheimer's disease affects millions of people worldwide, yet the illness is hardest to catch at the very beginning, when new treatments may work best. In a new study, Duke Health researchers show that a quick, outpatient ...

Prototype breath tests spot bacterial infections in minutes

Infectious diseases are a major cause of death worldwide, and diagnosing bacterial infections remains a challenge in medicine. And doing so reliably is more important than ever, given the increasing frequency of antibiotic ...

page 8 from 40